ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

HANS DIERCKSEN MD

275 ROUTE 30 N CASTLETON FAMILY HEALTH CENTER

Bomoseen | Vermont | 05732

(802) 468-5641

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,808Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 224

$669K Total Retail Price of All Prescriptions

Rank: 5 out of 224

429 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

8% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,339 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
SIMVASTATIN 619 489 1 1
HYDROCHLOROTHIAZIDE 552 462 2 6
LEVOTHYROXINE SODIUM 453 365 3 4
LISINOPRIL 446 384 4 2
METOPROLOL TARTRATE 401 350 5 7
WARFARIN SODIUM 375 335 6 10
OMEPRAZOLE 327 249 7 3
FUROSEMIDE 281 266 8 5
METOPROLOL SUCCINATE 271 237 9 11
AMLODIPINE BESYLATE 252 208 10 8
ATORVASTATIN CALCIUM 210 166 11 16
TRAMADOL HCL 202 145 12 18
METFORMIN HCL 187 118 13 9
HYDROCODONE-ACETAMINOPHEN 177 98 S3 14 12
POTASSIUM CHLORIDE 168 141 15 24
CITALOPRAM HBR 153 114 16 15
TRAZODONE HCL 147 125 17 20
KLOR-CON M20 146 131 18 81
GABAPENTIN 134 71 19 14
SERTRALINE HCL 130 68 20 17
NEXIUM 125 87 21 34
TAMSULOSIN HCL 117 96 22 30
GLIMEPIRIDE 107 83 23 88
VERAPAMIL ER 102 96 24 79
LANSOPRAZOLE 97 74 25 103
PANTOPRAZOLE SODIUM 89 68 26 27
LOSARTAN POTASSIUM 87 81 27 19
CLOPIDOGREL 83 74 28 70
SYNTHROID 79 77 29 74
FENTANYL 79 33 S2 29 49
NABUMETONE 78 62 31 138
AZITHROMYCIN 76 62 32 46
DICLOFENAC SODIUM 75 56 33 87
JANUVIA 75 57 33 75
SPIRIVA 75 71 33 32
RAMIPRIL 74 74 36 96
ALENDRONATE SODIUM 74 67 36 39
PAROXETINE HCL 73 53 38 52
PREDNISONE 73 65 38 28
DEXILANT 70 42 40 146
ADVAIR DISKUS 69 69 41 23
DIGOXIN 67 67 42 58
QUINAPRIL HCL 64 63 43 155
METFORMIN HCL ER 64 52 43 62
CARBIDOPA-LEVODOPA 62 47 45 80
ALLOPURINOL 62 50 45 40
FLOVENT HFA 59 54 47 86
GLIPIZIDE XL 59 58 47 63
PLAVIX 58 54 49 109
LIPITOR 55 42 50 94
PROAIR HFA 54 50 51 26
CEPHALEXIN 51 44 52 97
NORTRIPTYLINE HCL 50 25 53 179
ENALAPRIL MALEATE 50 45 53 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.